These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7926589)

  • 1. Gastric mucosal laminin receptor expression with ulcer healing by ebrotidine.
    Slomiany BL; Piotrowski J; Czajkowski A; Yotsumoto F; Majka J; Slomiany A
    Gen Pharmacol; 1994 May; 25(3):451-5. PubMed ID: 7926589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine.
    Slomiany BL; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
    Am J Gastroenterol; 1994 Jun; 89(6):894-7. PubMed ID: 8198101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle progression during gastric ulcer healing by ebrotidine and sucralfate.
    Slomiany BL; Piotrowski J; Slomiany A
    Gen Pharmacol; 1997 Sep; 29(3):367-70. PubMed ID: 9378241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement in gastric mucosal EGF and PDGF receptor expression with ulcer healing by sulglycotide.
    Piotrowski J; Majka J; Sano S; Nowak P; Murty VL; Slomiany A; Slomiany BL
    Gen Pharmacol; 1995 Jul; 26(4):749-53. PubMed ID: 7635250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement in gastric mucosal laminin receptor expression with ulcer healing.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1993 Sep; 31(1):105-12. PubMed ID: 8260933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroprotective and ulcer-healing activities of a new H2-receptor antagonist: ebrotidine.
    Brzozowski T; Majka J; Konturek SJ
    Digestion; 1992; 51(1):27-36. PubMed ID: 1353465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement in gastric mucosal laminin receptor expression with ulcer healing by sucralfate.
    Piotrowski J; Slomiany A; Sano S; Nowak P; Slomiany BL
    Biochem Mol Biol Int; 1994 Oct; 34(4):765-72. PubMed ID: 7866303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroprotective properties of ebrotidine. A review.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and healing of experimental indomethacin-induced gastric lesions: effects of ebrotidine, omeprazole and ranitidine.
    Arroyo MT; Lanas A; Sáinz R
    Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):313-8. PubMed ID: 10750652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement in the protective qualities of gastric mucus by ebrotidine during duodenal ulcer healing.
    Slomiany BL; Piotrowski J; Majka J; Czajkowski A; Slomiany A; Gabryelewicz A
    Gen Pharmacol; 1995 Sep; 26(5):1039-44. PubMed ID: 7557247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1, interleukin-4 and nitric oxide synthase modulators of gastric mucosal injury by indomethacin: effect of antiulcer agents.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 1999 Jun; 50(2):197-210. PubMed ID: 10424717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric mucosal cell cycle regulation with ulcer healing by sulglycotide.
    Slomiany BL; Piotrowski J; Slomiany A
    Scand J Gastroenterol; 1997 Sep; 32(9):873-7. PubMed ID: 9299663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of tumor necrosis factor-alpha and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine.
    Slomiany BL; Piotrowski J; Slomiany A
    Scand J Gastroenterol; 1997 Jul; 32(7):638-42. PubMed ID: 9246701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement in the protective qualities of gastric mucus with combination therapy of ebrotidine and amoxicillin for H. pylori eradication.
    Slomiany BL; Piotrowski J; Slomiany A; Konturek JW; Domschke WW
    Gen Pharmacol; 1998 Aug; 31(2):227-31. PubMed ID: 9688464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of interleukin-4 in down-regulation of endothelin-1 during gastric ulcer healing: effect of sucralfate.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 2000 Mar; 51(1):69-83. PubMed ID: 10768852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 1999 Sep; 50(3):391-404. PubMed ID: 10574469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of gastric mucus phospholipid secretion by an antiulcer agent, ebrotidine.
    Slomiany BL; Piotrowski E; Piotrowski J; Zirvi KA; Liau YH; Murty VL; Slomiany A
    Gen Pharmacol; 1994 Sep; 25(5):1033-7. PubMed ID: 7835621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of ebrotidine.
    Piotrowski J; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 Jun; 27(1):131-8. PubMed ID: 1385705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of gastric mucosal calcium channel activity by an antiulcer agent, ebrotidine.
    Slomiany BL; Liu J; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
    J Physiol Pharmacol; 1994 Mar; 45(1):121-31. PubMed ID: 7519082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of ebrotidine protection against gastric mucosal injury induced by ethanol.
    Slomiany BL; Piotrowski J; Murty VL; Slomiany A
    Gen Pharmacol; 1992 Jul; 23(4):719-27. PubMed ID: 1356875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.